Enter assignee name

% Expired Patents = 25.0

EPO Patents = 1

Trademarks = 3

Forward Citations = 5

Loading Chart...

26 inventors (with patents filed for the assignee):

Chia-Yu Huang (5 out of 12 patents)

Brian F McGuinness (5 out of 24 patents)

Jeffrey John Letourneau (4 out of 17 patents)

4. Venugopalareddy Bommireddy Venkata (3 out of 3 patents)

5. Axel Metzger (3 out of 11 patents)

6. David J Diller (3 out of 15 patents)

7. Kiruthika Selvarangan Elamparuthi (2 out of 2 patents)

8. Steven G Kultgen (2 out of 5 patents)

9. James R Beasley (2 out of 2 patents)

10. Michael S McQueney (2 out of 2 patents)

11. Rukiye Nazan Eraslan (2 out of 2 patents)

12. Jason Trama (2 out of 2 patents)

13. Grant E Gallagher (2 out of 25 patents)

14. Andrew G Cole (2 out of 5 patents)

15. Gary L Schieven (2 out of 10 patents)

8 patents: Sort by Forward Citations

1. 11883420 - Sting agonists for treating bladder cancer and solid tumors (2024-01-30),

2. 11583538 - Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors (2023-02-21),

3. 11306098 - Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors (2022-04-19),

4. 11236055 - Non-systemic TGR5 agonists (2022-02-01),

5. 11161864 - Sting agonists (2021-11-02),

6. 11110106 - Sting agonists for treating bladder cancer and solid tumors (2021-09-07),

7. 10669242 - toxin inhibitors (2020-06-02),

8. 10654834 - Non-systemic TGR5 agonists (2020-05-19),

Venenum Biodesign, LLC is a biotechnology company that specializes in designing novel therapies to tackle infectious diseases. With a focus on antimicrobial resistance and innovative drug discovery, Venenum Biodesign aims to develop cutting-edge solutions to combat global health challenges. Using advanced technologies and a multidisciplinary approach, the company strives to bring transformative treatments to market and improve patient outcomes.

Profile summary based on public USPTO records.